CHICAGO, IL / ACCESS Newswire / July 8, 2025 / Honeycomb Insurance, one of the fastest-growing insurtech companies in the U.S., today announced the opening of its new 15,000-square-foot headquarters in Chicago. The move follows a year of record growth for the company, which uses AI and proprietary computer vision to modernize property insurance for […]
Continuing to Strengthen its Doctor-Led Network Rooted in Clinical Excellence and Shared Values CHICAGO, IL / ACCESS Newswire / July 8, 2025 / Phase 1 Equity, a doctor-owned, doctor-led, and doctor-governed platform for orthodontists and pediatric dentists, is excited to welcome another leading multi-site and multi-doctor orthodontic practice based in Louisiana to its growing network.
NEW YORK CITY, NY / ACCESS Newswire / July 8, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against DoubleVerify Holdings, Inc. ("DoubleVerify" or the "Company") (NYSE:DV). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are
NEW YORK, NY / ACCESS Newswire / July 8, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against MicroStrategy Incorporated d/b/a Strategy ("Strategy" or the "Company") (NASDAQ:MSTR) and certain officers. The class action, filed in the United States District Court for the Eastern District of Virginia, and docketed under 25-cv-00861,
NEW YORK, NY / ACCESS Newswire / July 8, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Neogen Corporation ("Neogen" or "the Company") (NASDAQ:NEOG). Investors who purchased Neogen securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/NEOG. Investigation Details
NEW YORK CITY, NY / ACCESS Newswire / July 8, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sable Offshore Corp. ("Sable" or "the Company") (NYSE:SOC). Investors who purchased Sable securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/SOC.
NEW YORK CITY, NY / ACCESS Newswire / July 8, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Capricor Therapeutics, Inc. ("Capricor" or "the Company") (NASDAQ:CAPR). Investors who purchased Capricor securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/CAPR.
NEW YORK CITY, NY / ACCESS Newswire / July 8, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of TransMedics Group, Inc. ("TransMedics" or "the Company") (NASDAQ:TMDX). Investors who purchased TransMedics securities prior to February 3, 2022, and continue to hold to the present, are encouraged to obtain
NEW YORK CITY, NY / ACCESS Newswire / July 8, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of PACS Group, Inc. ("PACS Group" or "the Company") (NYSE:PACS). Investors who purchased PACS Group securities prior to April 11, 2024, and continue to hold to the present, are encouraged
NEW YORK, NY / ACCESS Newswire / July 8, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Apple Inc. ("Apple" or "the Company") (NASDAQ:AAPL). Investors who purchased Apple securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/AAPL. Investigation Details